2023
Recent Advances in DNA Origami-Engineered Nanomaterials and Applications
Zhan P, Peil A, Jiang Q, Wang D, Mousavi S, Xiong Q, Shen Q, Shang Y, Ding B, Lin C, Ke Y, Liu N. Recent Advances in DNA Origami-Engineered Nanomaterials and Applications. Chemical Reviews 2023, 123: 3976-4050. PMID: 36990451, PMCID: PMC10103138, DOI: 10.1021/acs.chemrev.3c00028.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsDNA origami techniquePaul RothemundDNA nanotechnologyOrigami techniqueExciting achievementsNanomaterialsMaterials scienceRecent progressRecent advancesNanotechnologyUseful applicationsApplicationsRothemundSignificant advancesUnexplored research avenuesOriginal proposalFieldPhysicsMathematicsEngineeringAdvancesUnique fieldNew uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders
Jamshed F, Dashti F, Ouyang X, Mehal W, Banini B. New uses for an old remedy: Digoxin as a potential treatment for steatohepatitis and other disorders. World Journal Of Gastroenterology 2023, 29: 1824-1837. PMID: 37032732, PMCID: PMC10080697, DOI: 10.3748/wjg.v29.i12.1824.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2020
Secretory Diarrhea
Ameen N, Kopic S, Ahsan K, Figueroa-Hall L. Secretory Diarrhea. Physiology In Health And Disease 2020, 41-76. DOI: 10.1007/978-3-030-55310-4_2.Peer-Reviewed Original Research
2019
Evaluation of Cervical Spine Injuries
Malhotra A, Malhotra A. Evaluation of Cervical Spine Injuries. Current Trauma Reports 2019, 5: 48-53. DOI: 10.1007/s40719-019-0163-5.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsCervical spine injurySignificant cervical spine injuryMagnetic resonance imagingSpine injuriesBlunt traumaCervical spineCT scanHigh-quality CT scansAdult patientsAbnormal findingsSummaryCurrent evidenceCurrent evidenceMRI scansResonance imagingInjuryTraumaScansCTSpinePatientsEvaluationTherapySignificant advancesRecent literature
2016
Paradoxical functions of ZEB1 in EGFR -mutant lung cancer: tumor suppressor and driver of therapeutic resistance
Yochum Z, Socinski M, Burns T. Paradoxical functions of ZEB1 in EGFR -mutant lung cancer: tumor suppressor and driver of therapeutic resistance. Journal Of Thoracic Disease 2016, 8: e1528-e1531. PMID: 28066651, PMCID: PMC5179406, DOI: 10.21037/jtd.2016.11.59.Peer-Reviewed Original ResearchNon-small cell lung cancerLung cancerEGFR-mutant lung cancerCell lung cancerCancer-related deathAmplification/mutationEGFR mutationsALK translocationKRAS mutationsDistinct subtypesTherapeutic resistanceCancerMolecular driversPatientsTumor suppressorParadoxical functionsMutationsSubtypesSignificant advancesZEB1
2015
Secretory Diarrhea
Ameen N, Kopic S, Ahsan M, Kravtsov D. Secretory Diarrhea. Physiology In Health And Disease 2015, 957-990. DOI: 10.1007/978-1-4939-3366-2_29.Peer-Reviewed Original ResearchLeigh syndrome: One disorder, more than 75 monogenic causes
Lake N, Compton A, Rahman S, Thorburn D. Leigh syndrome: One disorder, more than 75 monogenic causes. Annals Of Neurology 2015, 79: 190-203. PMID: 26506407, DOI: 10.1002/ana.24551.Peer-Reviewed Original ResearchImpact of recent innovations in the use of mass cytometry in support of drug development
Nassar AF, Ogura H, Wisnewski AV. Impact of recent innovations in the use of mass cytometry in support of drug development. Drug Discovery Today 2015, 20: 1169-1175. PMID: 26092491, PMCID: PMC4668584, DOI: 10.1016/j.drudis.2015.06.001.Peer-Reviewed Original ResearchConceptsSingle-cell technologiesSingle-cell levelDrug developmentSingle cellsDiseased statesCell levelMechanism of actionMass cytometryCellsDrug profilingIndividual biological cellsCyTOFImportant roleSignal overlapCytometryIndividual samplesBiological cellsProfilingSignificant advancesCell technologyMolecularly Targeted Therapies in Non–Small-Cell Lung Cancer Annual Update 2014
Morgensztern D, Campo MJ, Dahlberg SE, Doebele RC, Garon E, Gerber DE, Goldberg SB, Hammerman PS, Heist RS, Hensing T, Horn L, Ramalingam SS, Rudin CM, Salgia R, Sequist LV, Shaw AT, Simon GR, Somaiah N, Spigel DR, Wrangle J, Johnson D, Herbst RS, Bunn P, Govindan R. Molecularly Targeted Therapies in Non–Small-Cell Lung Cancer Annual Update 2014. Journal Of Thoracic Oncology 2015, 10: s1-s63. PMID: 25535693, PMCID: PMC4346098, DOI: 10.1097/jto.0000000000000405.Peer-Reviewed Original Research
2009
Point-of-Care Human Immunodeficiency Virus Testing
Campbell S, Fedoriw Y. Point-of-Care Human Immunodeficiency Virus Testing. Point Of Care The Journal Of Near-Patient Testing & Technology 2009, 8: 32-35. DOI: 10.1097/poc.0b013e31819b622d.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsRapid HIV testsHIV testHuman immunodeficiency virus (HIV) infectionHuman immunodeficiency virus (HIV) testingImmunodeficiency virus infectionRapid HIV testingHigh-risk individualsPublic health testingHIV testingVirus infectionVirus testingDrug AdministrationRapid diagnosisEffective disease managementHealth careDisease managementCareClinical laboratoriesDiagnosisHealth testingRecent studiesInfectionOperational barriersSignificant advancesAdministration
2005
Role of novel targeted therapies in the clinic
Herbst RS. Role of novel targeted therapies in the clinic. British Journal Of Cancer 2005, 92: s21-s27. PMID: 15928655, PMCID: PMC2362061, DOI: 10.1038/sj.bjc.6602605.Peer-Reviewed Original Research
2002
Significance of beta‐blockers in the perioperative period
Akhtar S, Barash PG. Significance of beta‐blockers in the perioperative period. Current Opinion In Anaesthesiology 2002, 15: 27. PMID: 17019181, DOI: 10.1097/00001503-200202000-00005.Peer-Reviewed Original Research
1998
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AS MARKERS FOR SYSTEMIC AUTOIMMUNE DISEASE
Homer R. ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES AS MARKERS FOR SYSTEMIC AUTOIMMUNE DISEASE. Clinics In Chest Medicine 1998, 19: 627-639. PMID: 9917957, DOI: 10.1016/s0272-5231(05)70107-6.Peer-Reviewed Original ResearchConceptsAntineutrophil cytoplasmic antibodyCytoplasmic antibodiesSpectrum of diseaseAntigen-specific assaysANCA testingSystemic vasculitisChest PhysiciansAutoimmune diseasesPretest probabilitySpecific antigenClinical useDiseaseSpecific testingSpecific assayAntibodiesAccurate assessmentVasculitisAntigenPhysiciansSignificant advancesConsistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells
Robbins P, Skelton D, Yu X, Halene S, Leonard E, Kohn D. Consistent, persistent expression from modified retroviral vectors in murine hematopoietic stem cells. Proceedings Of The National Academy Of Sciences Of The United States Of America 1998, 95: 10182-10187. PMID: 9707621, PMCID: PMC21482, DOI: 10.1073/pnas.95.17.10182.Peer-Reviewed Original ResearchMeSH KeywordsAnimalsBase SequenceBone Marrow TransplantationColony-Forming Units AssayDNA MethylationDNA PrimersDNA, RecombinantFemaleFounder EffectGene ExpressionGene Transfer TechniquesGenetic VectorsHematopoietic Stem CellsMaleMiceMice, Inbred C57BLMoloney murine leukemia virusRepetitive Sequences, Nucleic AcidRetroviridaeTransduction, GeneticTransplantation, IsogeneicVirus IntegrationAn ancient system of host defense
Medzhitov R, Janeway C. An ancient system of host defense. Current Opinion In Immunology 1998, 10: 12-15. PMID: 9523104, DOI: 10.1016/s0952-7915(98)80024-1.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply